Co-treatment with vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer

Categoría del artículo: Research Article

Publicado en línea: 07 abr 2022

Páginas: 185 - 197

Recibido: 26 sept 2021

Aceptado: 28 ene 2022

DOI: https://doi.org/10.2478/raon-2022-0012

Palabras clave

vactosertib, transforming growth factor-β (TGF-β), radiotherapy, epithelial-to-mesenchymal transition, cancer stem cell, breast cancer

© 2022 Jiwon Choi, Jiyoung Park, Ilyoung Cho, Yhunyhong Sheen, published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.